Lehrstuhl für Urologie

Timing of androgen deprivation monotherapy and combined treatments in castration-sensitive and castration-resistant prostate cancer: a narrative review (2019) Kunath F, Goebell P, Wullich B, Sikic D, Kahlmeyer A Journal article, Review article sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitro (2019) Tsaur I, Hüsch T, Jüngel E, Schneider F, Schneider M, Haferkamp A, Thomas C, et al. Journal article New horizons in bladder cancer research (2019) Boormans JL, Zwarthoff EC, Black PC, Goebell P, Kamat AM, Nawroth R, Seiler R, et al. Journal article, Review article Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab (2019) Eckstein M, Erben P, Kriegmair MC, Worst TS, Weiss CA, Wirtz RM, Wach S, et al. Journal article High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma (2019) Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stoeckle M, Becker F, et al. Journal article Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na+/K+ -ATPase inhibition. (2018) Silva IT, Munkert J, Nolte E, Schneider NFZ, Rocha SC, Ramos ACP, Kreis W, et al. Journal article, Original article The impact of the androgen receptor splice variant AR-V7 on the prognosis and treatment of advanced prostate cancer (2018) Thelen P, Taubert H, Duensing S, Kristiansen G, Merseburger AS, Cronauer MV Journal article Prospective evaluation of geriatric assessment tools as predictors of functional outcome in old patients undergoing major urologic tumor surgery (2018) Kahlmeyer A, Losensky W, Sikic D, Wach S, Ritt M, Goebell P, Keck B, Wullich B Conference contribution Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients (2018) Rot S, Kaune T, Greither T, Kotrba J, Bache M, Al-Nawas B, Vordermark D, et al. Conference contribution A multicenter comparison of PD-L1 protein and mRNA expression in urothelial bladder cancer by immunohistochemistry and RT-qPCR (Checkpoint-Typer(C)): A round robin test by the BRIDGE-Consortium Germany (2018) Eckstein M, Wirtz R, Pfannstil C, Wach S, Stoehr R, Breyer J, Erlmeier F, et al. Conference contribution